Drug Week
Susan Hasty, Publisher
Table of Contents . . . July 6th, 2001
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Drug Week | Other Publications
Drug Development - Virus Found To Carry Antibiotic Against E. coli
Drug Safety - Study Suggests Potential Alzheimer Drugs Might Be Dangerous
Cancer Therapies - Combining Treatments With Glycolytic Inhibitors Gets To Core Of Tumors
Diabetic Retinopathy - Jury Still Out On Effect Of Thiazolidinediones On Eye Disease
Myasthenia Gravis - Peptide Vaccine Ready For Testing In Humans
Osteoporosis - Statins May Reduce Risk Of Bone Fractures
Pharmacodynamics - Aspirin Targets Key Cell That Triggers Organ Rejection And Other Immune Responses
AIDS Therapies - Immunotherapy With Strategic Interruptions Evaluated
Adverse Drug Effects - Previous Short-Term Use Of Fenfluramine Not Associated With Increased Risk Of Drug-Related Heart Disease
Asthma - Phase II Clinical Trial Anti-inflammatory Compound Initiated
Autoimmune Disorders - Immune Modulation Therapy Inhibits Inflammation
Dementia - Proof Of Concept Efficacy In Phase IIa Clinical Trials Reported
Drug Development - Compound's Anti-Obesity Properties Confirmed In Second Gerbil Study
Drug Safety - Fake And Poor-Quality Drugs Common In Less-Developed Countries
Epidemiology - Antibiotic-Resistant Streptococcus On The Rise
Head and Neck Cancer - New Drug Helps Reduce Dry Mouth Problem
Immunosuppression - Data Support Efficacy/Safety Of Novel Lymphocyte Homing Agent
Interstitial Cystitis - Pentosan Polysulfate Sodium Is Highly Effective Therapy
Juvenile Rheumatoid Arthritis - Oral Human Gamma Globulin Receives Orphan Drug Status
Kidney Transplantation - Study Data Presented Comparing Immunosuppressants
Overactive Bladder - Data Reported From Comparison Study
Psoriasis - Topical Antisense Therapy Improves Pathology
Renal Transplantation - CerticanTM Effectively Prevents Acute Rejection
Therapy (HBV) - New Compound Shows Promise
Therapy (HBV) - Phase I Study Of Adefovir Dipivoxil Initiated In China
Varicose Veins - VarisolveR Trials Prove Efficacy and Safety of New Treatment
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
